In a first study of its kind, USC researchers have found that colorectal cancer risk in Californian Latinos vary widely depending on their country of origin.
Latinos are the largest and fastest growing minority ethnic group in America.
Some 14.7 million Latinos live in California.
They represent 38.4 percent of the state's population and 27 percent of the entire U.S. Latino population, according to the U.S. Census Bureau.
"Hispanics are a very heterogeneous population, which is not really recognised in most cancer studies," said Mariana Stern, lead author, a cancer epidemiologist and associate professor of preventive medicine in the Keck School of Medicine of USC.
"Their risk factors might be different; their clinical characteristics could be different. We have to zoom into these observations and understand these disparities because they may affect how patients are educated about the disease and how they are treated by doctors."
The study was published online in Cancer Causes & Control.
USC researchers used California Cancer Registry data.
They examined the profiles of 36,133 Latinos and 174,710 whites who were diagnosed with colorectal cancer between 1995 and 2011.
Latinos were further identified by their country of origin: Mexico, Cuba, Puerto Rico, Central or South America, or not specified.
USC researchers hope to pave the road toward personalised cancer care.
"Nowadays, most of the information we have on the molecular characteristics of colorectal cancer comes from the white population," said Stern, who is Latina.
"There is little information specific to Latinos. Plus, they are typically clumped as a group."
Finding Highlights
Study Significance
"We have pioneered surveillance of ethnic differences in cancer risk," said Lihua Liu, senior author, assistant professor of clinical preventive medicine at Keck Medicine of USC and a research scientist in the Los Angeles Cancer Surveillance Program.
"We have previously shown dramatic differences in cancer risk among Asian subgroups. It's time to also examine the heterogeneity within Latinos."
However, hospitals and clinics in California do not have a standardised practice for collecting detailed ethnic and birthplace information, which resulted in a large proportion of Latino patients without country of origin information, posing a notable weakness of the study.
Standardising ethnic and birthplace data collection will help guide future cancer control strategies, Liu said.
The objective is to reduce the impact of cancer, the leading cause of death in the Latino community.
In contrast, the No. 1 cause of death among whites is heart disease, followed by cancer.
Genetics, varying degrees of inter-mixing as well as acculturation to the U.S. lifestyle could all influence colorectal cancer incidence rates.
For example, Latinos from the Caribbean generally have more African and fewer indigenous American forefathers.
People from Mexico, however, have a larger proportion of indigenous American ancestry than Puerto Ricans or Cubans, Stern said.
"Maybe the biology of people from Mexico protects them from developing colorectal cancer," she added.
"This has been reported for breast cancer too. The heterogeneity of Latino populations presents a unique opportunity to disentangle the complex role of socio-demographics, culture, lifestyle and genetics as potential determinants of colorectal cancer risk among Latinos and other populations."